课题基金 / 基金详情

Early Detection of Vascular Dysfunction Using Biomarkers from Lagrangian Carotid Strain Imaging

Early Detection of Vascular Dysfunction Using Biomarkers from Lagrangian Carotid Strain Imaging
使用拉格朗日颈动脉应变成像生物标志物早期检测血管功能障碍
批准号:
10653121
负责人:
TOMY VARGHESE
金额:
$58.49万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-15 至 2024-06-30

项目摘要

项目成果

TOMY VARGHESE的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 目前治疗动脉粥样硬化斑块或动脉粥样硬化的临床标准主要集中在 血管狭窄的百分比。然而,闭塞的测量(狭窄百分比)并不能识别出那些 容易破裂的斑块,可能会将血栓释放到为敏感大脑供血的血流中 脉管系统一种新的方法,拉格朗日颈动脉应变成像,其中组织位移精确 已经开发了在通过动脉的血液脉动期间测量的测量方法。我们建议测量`应变 指数,包括在心脏上估计的最大累积轴向、侧向和剪切应变 循环,以探测早期牙菌斑的详细机械性能。我们相信这些应变指数将证明 是有价值的血管生物标志物,以指示血管老化和可能的斑块脆弱性。 我们的初步结果表明,有能力区分软,硬地区的斑块 在体内临床成像条件下。我们对“易损斑块”或“易损患者”的定义依赖于 识别沉积物或较软的斑块,即,那些经历大的轴向或横向 变形和/或大的剪切应变。应变张量成像能力, 从早期阶段到成熟斑块病变表征斑块严重性的血管生物标志物将是 评估和量化。 还提出了对无症状志愿者和患者的研究。志愿者将提供价值观 血管应变指数归一化为年龄相关的血管硬化。结果将使我们能够建立 血管硬度的年龄相关变化趋势,并确定可以建立血管硬度的偏差。 老化标准然后可能会使用逆转血管老化的干预措施,例如改变生活方式 和普通的医学治疗。应变成像结果将由三个方面进行验证和补充- 三维(3D)颈动脉磁共振成像(MRI)对选定的一组高危志愿者,沿着 用3D颈动脉MRI和3D组织病理学分析整个切除斑块对患者进行更好的 了解斑块的组成和结构。验证我们的结果将促进使用实时非侵入性 超声应变成像作为识别易受血管老化影响的人类受试者的筛选工具 和/或形成易于破裂或微栓塞的斑块,这可能导致“无症状中风”, 血管性认知障碍患者研究还将能够比较应变指数和颈动脉MRI 到地面的真相,即切除的斑块。
英文摘要
Abstract Current clinical criteria for treatment of atherosclerotic plaque, or atheromas, have focused primarily on percent stenosis of the vessel. However, measures of occlusion (percent stenosis) do not identify those plaques that are prone to rupture, which may release emboli into the blood stream feeding sensitive cerebral vasculature. A novel approach, Lagrangian carotid strain imaging, where tissue displacements are precisely measured during pulsation of blood through the artery has been developed. We propose to measure `strain indices,' that include the maximum accumulated axial, lateral, and shear strain estimated over the cardiac cycle, to probe the detailed mechanical properties of early plaque. We believe these strain indices will prove to be valuable vascular biomarkers to indicate vascular aging and possible plaque vulnerability. Our preliminary results demonstrate the ability to differentiate between soft and stiff regions in plaque under in-vivo clinical imaging conditions. Our definition of `vulnerable plaque' or `vulnerable patient' relies on the identification of lipidic depositions or softer plaques, i.e., those that undergo large axial or lateral deformations and/or large shearing strains during the cardiac cycle. Capability of strain tensor imaging and vascular biomarkers to characterize plaque severity from its early stages to a mature plaque lesion will be evaluated and quantified. A study on asymptomatic volunteers and patients also is proposed. The volunteer will provide values for vascular strain indices normalized to age-related vascular stiffening. The results will enable us to establish trends in age-related variations in vascular stiffness and to determine deviations that could establish vascular aging criteria. Interventions to reverse vascular aging might then be used, for example lifestyle modifications and common medical therapies. Strain imaging results will be validated and complimented by three- dimensional (3D) carotid magnetic resonance imaging (MRI) on a selected group of high-risk volunteers, along with 3D carotid MRI and 3D histopathological analysis of the entire excised plaque on patients to better understand plaque composition and structure. Validation of our results will foster use of real-time noninvasive ultrasound strain imaging as a screening tool for identifying human subjects susceptible to vascular aging and/or developing plaque prone to rupture or micro-embolization that could lead to `silent strokes' and possible vascular cognitive impairment. The patient study will also enable comparison of strain indices and carotid MRI to the ground truth, namely the excised plaque.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1109/embc44109.2020.9175911
发表时间: 2020-07
期刊: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
影响因子: --
作者: [Meshram NH, Jackson D, Mitchell CC, Wilbrand SM, Dempsey RJ, Hermann BP, Varghese T]
通讯作者: Varghese T
DOI: 10.1109/embc44109.2020.9176531
发表时间: 2020-07
期刊: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
影响因子: --
作者: [Mukaddim RA, Varghese T]
通讯作者: Varghese T
DOI: 10.1177/0161734620951216
发表时间: 2020-07
期刊: Ultrasonic imaging
影响因子: 2.3
作者: [Meshram NH, Mitchell CC, Wilbrand S, Dempsey RJ, Varghese T]
通讯作者: Varghese T
DOI: 10.1109/embc46164.2021.9630278
发表时间: 2021-11
期刊: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
影响因子: --
作者: [Al Mukaddim R, Ahmed R, Varghese T]
通讯作者: Varghese T
Early Detection of Vascular Dysfunction Using Biomarkers from Lagrangian Carotid Strain Imaging
  • 批准号:
    10442390
  • 项目类别:
  • 资助金额:
    $58.18万
  • 财政年份:
    2020
  • 负责人:
    TOMY VARGHESE
  • 依托单位:
Early Detection of Vascular Dysfunction Using Biomarkers from Lagrangian Carotid Strain Imaging
  • 批准号:
    10214678
  • 项目类别:
  • 资助金额:
    $64.6万
  • 财政年份:
    2020
  • 负责人:
    TOMY VARGHESE
  • 依托单位:
Early Detection of Vascular Dysfunction Using Biomarkers from Lagrangian Carotid
  • 批准号:
    10490566
  • 项目类别:
  • 资助金额:
    $35.99万
  • 财政年份:
    2020
  • 负责人:
    TOMY VARGHESE
  • 依托单位:
Ultrasonic and Photoacoustic Imaging System for Cancer & Cardiovascular Research
  • 批准号:
    8734742
  • 项目类别:
  • 资助金额:
    $90.79万
  • 财政年份:
    2015
  • 负责人:
    TOMY VARGHESE
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: